Navigation Links
Oncothyreon to present at BIO Investor Forum 2008
Date:10/24/2008

SEATTLE, Oct. 24 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the 7th Annual BIO Investor Forum in San Francisco on Friday, October 31, 2008 at 8:00 a.m. Pacific Time.

A live and archived webcast of Dr. Kirkman's presentation can be accessed at http://www.oncothyreon.com under the "News & Events" section.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit http://www.oncothyreon.com.


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
2. Oncothyreon announces prioritization plan for development programs
3. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
4. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
5. Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
6. Oncothyreon to receive milestone payment
7. Oncothyreon Reports First Quarter 2008 Financial Results
8. Oncothyreon files investigational new drug application for PX-866 oncology compound
9. Data for Oncothyreons PX-12 and PX-866 presented at AACR Annual Meeting
10. Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
11. Oncothyreon announces effectiveness of shelf registration statement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...l temperatures and energy costs continue to soar, ...inable future. An attractive replacement for gas...ine in Genome Research ( www.genome.org ), scien...hanol-producing microorganisms, uncovering genetic...hnologies needed to implement production on a glob...
(Date:11/6/2009)...6 Helix BioPharma Corp. ...nced that John Docherty, president and chief opera...,s 6th annual Investor Summit on November 10, 2009... Mr. Docherty will provide an overview of the Com...7 and Topical Interferon Alpha-2b. The slide show...
(Date:11/6/2009)...swire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ON...day announced updated results from a Phase II stud...omas metastatic to the lung in a poster presentati...ociety Meeting held in Miami Beach, Florida, from ...tled "A Phase II Study of Intravenous REOLYSIN (Wi...
(Date:11/5/2009).... 5 The endangered black-footed fe.... This rare carnivore feeds on prairie dogs. Th...often entire population die-offs in towns occur. ...lemented a ferret breeding program and has been re...ly native habitat. Unfortunately, plague can swee...
Breaking Biology Technology:Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
Miller Brewing selects Procuri software
...enter business of Telstar Communications, Inc. o... of Minneapolis, in a deal that closed Aug. 25, th...is an application and systems integration company,...aging, contact center and IP telephony systems. , ...upaca Telephone and evolved into Telstar. It is an...
...sin Alumni Research Foundation has reached an out...gy firm IBM over charges of patent infringement,...fringing on patented technology by marketing and s...at are based on WARF,s technology. A trial was sch...oth sides are happy with the agreement," WARF spok...
Other Biology Technology:WARF settles patent dispute with IBM 2
(Date:11/9/2009)...logists have had their hands tied because more tha...sable a protein called p53. As a critical anti-can...ing operations within cells. When cells lose p53, ...ed. , These tumors might be tough, but they,re ...ing Harbor Laboratory (CSHL). The chink in the tum...
(Date:11/9/2009)...wings has inspired a 3.2m, three-year research pro...elds of security, energy and the environment. The ...company QinetiQ have just signed a collaborative c...dbreaking physical sciences research. , Over th...niversity of Exeter and QinetiQ will work together...
(Date:11/9/2009)...9 A nutritionist whose research was instrumental ...en, Infants and Children (WIC) food subsidy will r...outstanding achievement in the field of maternal-f... a professor in the Department of Community Health...eles School of Public Health, will receive the awa...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Covance to Present at William Blair 26 Companys 29th Annual Growth Stock Conference 48178 1Companion Global Healthcare Inc Offers Additional Hospital Choices to Employers Individuals Looking to Save on Fully Credentialed Health Care 48175 1Companion Global Healthcare Inc Offers Additional Hospital Choices to Employers Individuals Looking to Save on Fully Credentialed Health Care 48175 2CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 12522 1CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 12522 2CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 12522 3
...essor of biology in Arts & Sciences, has made a br...eolar dominance, the silencing of an entire parent... animal. , Since the machinery involved in nucl... can go haywire in diseases such as cancer, Pikaar...nt implications for applied medical research. , ...
...onefish from Miami down to the Marquesas Islands, ... down slightly from the average of previous census...e who are counting, researchers speculate. The Uni... Atmospheric Science held the sixth annual Florida...servation group Bonefish & Tarpon Unlimited (BTU),...
...ting of skeletal muscle, chronic inflammation of t...bs can result in significant physical impairment....y and community health professor Kimberly Huey, pa...properties of Vitamin E may be associated with red...nes, in vitro, in various types of cells. Cytokine...
Other Biology News:Researchers solve piece of large-scale gene silencing mystery 2Researchers solve piece of large-scale gene silencing mystery 3Researchers solve piece of large-scale gene silencing mystery 4Bonefish census reveals population holding steady 2Vitamin E shows possible promise in easing chronic inflammation 2Vitamin E shows possible promise in easing chronic inflammation 3
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Mouse Anti-IFN-g / CD69 / CD4 / CD3 BDFastImmune Antibody, APC, PerCP-Cy5.5, PE, FITC Conjugated from BD Biosciences - Immunocytometry Systems
Mouse Anti-Transferrin, N-terminus Monoclonal Antibody, Unconjugated, Clone 236-18241 from Meridian Life Science, Inc.
Rabbit Anti-Phosphothreonine-X-Phosphotyrosine Polyclonal Antibody, Horseradish Peroxidase Conjugated from Abcam
Biology Products: